Arizona State Retirement System boosted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 8.5% in the 4th ...

A new Pitchbook report found $4.3 billion in funding to women-fronted biotech companies across 121 deals. The increase comes ...

Officers, 10% owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks in the ...

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) saw a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 3,900 shares, ...

CARVYKTI® net trade sales of approximately $334 million and $963 million for the fourth quarter and full year 2024, respectivelyOver 5,000 ...

The term "game-changing" is overused for too many up-and-coming companies, but in this case, the description fits.

Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with ...

The stock makes the NASDAQ top percentage gainers list on acquisition news today, currently trading at $8.44, up 3.48, ...

The latest data identifies biohealth as a bright spot in VC funding for female founders, most significantly in the Northeast.

Shares of Krystal Biotech KRYS have gained 15.8% in the past month compared with the industry’s growth of 4%. The stock has also outperformed the industry and the sector in this timeframe.

H.C. Wainwright lowered the firm’s price target on Moleculin Biotech (MBRX) to $8 from $45 and keeps a Buy rating on the shares. The firm adjusted its model to the effect of a 1-for-15 reverse ...